Auscann Group Holdings Stock Current Ratio
| ACNNFDelisted Stock | USD 0 0.0007 22.58% |
AusCann Group Holdings fundamentals help investors to digest information that contributes to AusCann Group's financial success or failures. It also enables traders to predict the movement of AusCann Pink Sheet. The fundamental analysis module provides a way to measure AusCann Group's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to AusCann Group pink sheet.
AusCann |
AusCann Group Holdings Company Current Ratio Analysis
AusCann Group's Current Ratio is calculated by dividing the Current Assets of a company by its Current Liabilities. It measures whether or not a company has enough cash or liquid assets to pay its current liability over the next fiscal year. The ratio is regarded as a test of liquidity for a company.
Current AusCann Group Current Ratio | 23.92 X |
Most of AusCann Group's fundamental indicators, such as Current Ratio, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, AusCann Group Holdings is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Typically, short-term creditors will prefer a high current ratio because it reduces their overall risk. However, investors may prefer a lower current ratio since they are more concerned about growing the business using assets of the company. Acceptable current ratios may vary from one sector to another, but the generally accepted benchmark is to have current assets at least as twice as current liabilities (i.e., Current Ration of 2 to 1).
CompetitionIn accordance with the recently published financial statements, AusCann Group Holdings has a Current Ratio of 23.92 times. This is much higher than that of the Healthcare sector and significantly higher than that of the Drug Manufacturers—Specialty & Generic industry. The current ratio for all United States stocks is notably lower than that of the firm.
AusCann Current Ratio Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses AusCann Group's direct or indirect competition against its Current Ratio to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of AusCann Group could also be used in its relative valuation, which is a method of valuing AusCann Group by comparing valuation metrics of similar companies.AusCann Group is currently under evaluation in current ratio category among its peers.
AusCann Fundamentals
| Return On Equity | -0.8 | |||
| Return On Asset | -0.0964 | |||
| Operating Margin | (2.40) % | |||
| Current Valuation | (2.97 M) | |||
| Shares Outstanding | 440.55 M | |||
| Shares Owned By Insiders | 12.71 % | |||
| Shares Owned By Institutions | 16.42 % | |||
| Price To Earning | (53.62) X | |||
| Price To Book | 0.07 X | |||
| Price To Sales | 7.99 X | |||
| Revenue | 29.73 K | |||
| Gross Profit | 336.67 K | |||
| EBITDA | (5.07 M) | |||
| Net Income | (26.36 M) | |||
| Cash And Equivalents | 5.76 M | |||
| Cash Per Share | 0.01 X | |||
| Total Debt | 39.87 K | |||
| Debt To Equity | 0 % | |||
| Current Ratio | 23.92 X | |||
| Book Value Per Share | 0.04 X | |||
| Cash Flow From Operations | (2.83 M) | |||
| Earnings Per Share | (0.01) X | |||
| Number Of Employees | 14 | |||
| Beta | 0.96 | |||
| Market Capitalization | 11.83 M | |||
| Total Asset | 18.45 M | |||
| Net Asset | 18.45 M |
About AusCann Group Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze AusCann Group Holdings's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of AusCann Group using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of AusCann Group Holdings based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Other Consideration for investing in AusCann Pink Sheet
If you are still planning to invest in AusCann Group Holdings check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the AusCann Group's history and understand the potential risks before investing.
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Equity Valuation Check real value of public entities based on technical and fundamental data |